Tech Company Financing Transactions
Costim Pharmaceuticals Funding Round
Costim Pharmaceuticals closed a $10 million financing round on 3/31/2013. Backers included Atlas Venture, MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$10,005,000
Round
Undisclosed
Investors
Atlas Venture (Jean-François Formela)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
200 Clarendon Street 54th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Not Recorded
Overview
The company is developing a focused and highly attractive pipeline of antibody agents directed to costimulatory targets for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Millman
Browse more venture capital transactions:
Prev: 3/31/2013: Enerpulse venture capital transaction
Next: 3/31/2013: Afferent Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs